# Study of Neurological Damage From Coronavirus Disease (COVID-19)

> **NCT05079373** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 250 (estimated)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05079373
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-10-09
- **Final completion:** 2022-10-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079373, "Study of Neurological Damage From Coronavirus Disease (COVID-19)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05079373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*